Fibrolamellar hepatocarcinoma is a rare subtype of cancer that preferably affects young individuals. Unlike common HCC, patients with fibrolamellar HCC lack any underlying liver disease. There is limited information regarding genomic alterations in this tumor. This project aims to uncover major molecular alterations in this tumor and compare findings with other liver tumors with different lineages (cholangiocarcinoma, HCC).
Translational research in liver cancer